Neoadjuvant Cobimetinib and Atezolizumab with or Without Vemurafenib for High-Risk Operable Stage III Melanoma: the Phase II NeoACTIVATE Trial
NATURE COMMUNICATIONS（2024）
Key words
Melanoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined